The additive in vitro anti-HIV-1 effect of chloroquine, when combined withzidovudine and hydroxyurea

Citation
Jr. Boelaert et al., The additive in vitro anti-HIV-1 effect of chloroquine, when combined withzidovudine and hydroxyurea, BIOCH PHARM, 61(12), 2001, pp. 1531-1535
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOCHEMICAL PHARMACOLOGY
ISSN journal
00062952 → ACNP
Volume
61
Issue
12
Year of publication
2001
Pages
1531 - 1535
Database
ISI
SICI code
0006-2952(20010615)61:12<1531:TAIVAE>2.0.ZU;2-4
Abstract
The 4-aminoquinoline chloroquine and its analogue hydroxychloroquine are en dowed with anti-HN-l activity both in vitro and in vivo. We previously repo rted that the addition of CQ (chloroquine) to the combination of HU (hydrox yurea) and ddI (didanosine) provides additive anti-HIV-l activity. We here extended this in vitro investigation by studying whether the addition of CQ also resulted in additive anti-HIV-1 activity when combined with HU plus A ZT (zidovudine). The same effect was found, whether CQ was added to HU plus AZT or to HU plus ddI, in recently infected H-9 and U-937 cells or primary T cells and monocytes, as well as in immunologically or oxidatively stimul ated ACH-2 and U-l tells. At concentrations where CQ exerts its anti-HIV-l effect in combination with the other drugs, CQ addition does not result in either cell toxicity or apoptosis. (C) 2001 Elsevier Science Inc. All right s reserved.